Oculis (OCS) Earnings Date, Estimates & Call Transcripts $14.91 -0.11 (-0.73%) (As of 11/20/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Oculis Latest Earnings SummaryUpcoming Q3 Earnings DateMar. 17EstimatedActual EPS (Aug. 27) -$0.56 Missed By -$0.13 Consensus EPS (Aug. 27) -$0.43 Oculis announced Q2 2024 earnings on August 27, 2024, reporting an EPS of -$0.56, which missed the consensus estimate of -$0.43 by $0.13. Quarterly revenue was reported to be $0.27 million, below analysts' expectations of $0.28 million. With a trailing EPS of -$1.93, Oculis' earnings are expected to grow next year, from ($2.09) to ($2.05) per share. OCS Upcoming EarningsOculis' next earnings date is estimated for Monday, March 17, 2025, based off prior year's reporting schedules. Get Oculis Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oculis and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOCS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OCS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Oculis Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.40-$0.36-$0.38Q2 20242-$0.42-$0.42-$0.42Q3 20242-$0.51-$0.51-$0.51Q4 20242-$0.51-$0.50-$0.51FY 20248-$1.84-$1.79-$1.82Q1 20251-$0.49-$0.49-$0.49Q2 20251-$0.49-$0.49-$0.49Q3 20251-$0.49-$0.49-$0.49Q4 20251-$0.49-$0.49-$0.49FY 20254($1.96)($1.96)($1.96) Oculis Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/17/2025(Estimated)------- 8/27/2024Q2 2024-$0.43-$0.56 -$0.13-$0.56$0.28M$0.27M5/8/2024Q1 2024-$0.41-$0.44 -$0.03-$0.44$0.28M$0.22M 3/18/2024Q4 2023-$0.42-$0.38+$0.04-$0.38$0.28M$0.21M 11/15/2023Q3 2023-$0.36-$0.38 -$0.02-$0.22$0.30M$0.25M 8/29/2023Q2 2023-$0.33-$0.42 -$0.09-$0.42$0.28M$0.28M Oculis Earnings - Frequently Asked Questions When is Oculis's earnings date? Oculis has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates. Learn more on OCS's earnings history. Did Oculis beat their earnings estimates last quarter? In the previous quarter, Oculis (NASDAQ:OCS) missed the analysts' consensus estimate of ($0.43) by $0.13 with a reported earnings per share (EPS) of ($0.56). Learn more on analysts' earnings estimate vs. OCS's actual earnings. How much revenue does Oculis generate each year? Oculis (NASDAQ:OCS) has a recorded annual revenue of $980,000.00. How much profit does Oculis generate each year? Oculis (NASDAQ:OCS) has a recorded net income of -$98.92 million. OCS has generated -$1.93 earnings per share over the last four quarters. What is Oculis's EPS forecast for next year? Oculis's earnings are expected to grow from ($2.09) per share to ($2.05) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Longboard Pharmaceuticals Earnings Arrowhead Pharmaceuticals Earnings Protagonist Therapeutics Earnings IDEAYA Biosciences Earnings CG Oncology Earnings Keros Therapeutics Earnings Wave Life Sciences Earnings Akero Therapeutics Earnings Amphastar Pharmaceuticals Earnings Apogee Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW This page (NASDAQ:OCS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
